Anti- N-methyl-d-aspartate Receptor Encephalitis: A Case Series and Review of the Literature

J Pediatr Neurosci. 2019 Oct-Dec;14(4):180-185. doi: 10.4103/jpn.JPN_83_19. Epub 2019 Dec 3.

Abstract

Anti-NMDAR (N-methyl-d-aspartate receptor) encephalitis is a potentially severe form of encephalitis associated with antibodies against NR1 and NR2 subunits of the NMDAR. Anti-NMDAR encephalitis is a treatable cause of encephalitis. An underlying tumor should be actively looked for as this is also considered to be a paraneoplastic syndrome. We report two children with anti-NMDAR encephalitis with a literature review of current evidence in diagnosing and managing this rare condition. Resection of the tumor, glucocorticoids, intravenous immunoglobulin, and plasma exchange often result in improvement, usually within four weeks. Outcome corresponds with the rapidity of commencing appropriate treatment.

Keywords: Encephalitis; N-methyl-d-aspartate; N-methyl-d-aspartate receptor.

Publication types

  • Review